Immutep Limited (NASDAQ:IMMP) Shares Acquired by Meridian Wealth Management LLC

Meridian Wealth Management LLC boosted its holdings in Immutep Limited (NASDAQ:IMMPFree Report) by 3.6% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 322,450 shares of the biotechnology company’s stock after purchasing an additional 11,250 shares during the quarter. Meridian Wealth Management LLC’s holdings in Immutep were worth $774,000 as of its most recent filing with the Securities and Exchange Commission.

Immutep Trading Up 1.4 %

Shares of IMMP opened at $2.96 on Friday. Immutep Limited has a fifty-two week low of $1.58 and a fifty-two week high of $3.09. The company’s fifty day moving average is $2.59 and its two-hundred day moving average is $2.34.

Analysts Set New Price Targets

Separately, Capital One Financial assumed coverage on Immutep in a report on Friday. They issued an “overweight” rating and a $10.00 price target for the company.

Check Out Our Latest Stock Analysis on IMMP

Immutep Profile

(Free Report)

Immutep Limited, a clinical-stage biotechnology company, engages in developing novel LAG-3 Immunotherapy for cancer and autoimmune diseases. The company is involved in advancing therapeutics related to Lymphocyte Activation Gene-3 (LAG-3), a cell surface molecule that plays a vital role in regulating the immune system.

See Also

Want to see what other hedge funds are holding IMMP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Immutep Limited (NASDAQ:IMMPFree Report).

Institutional Ownership by Quarter for Immutep (NASDAQ:IMMP)

Receive News & Ratings for Immutep Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Immutep and related companies with MarketBeat.com's FREE daily email newsletter.